[Rifampicin: a new antitubercular agent].
D055598:Chemical Phenomena; D002621:Chemistry; D004361:Drug Tolerance; D005069:Evaluation Studies as Topic; D006801:Humans; D012293:Rifampin / Q000032:analysis / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy
D012293:Rifampin
Rifampicyna (RFP)--nowy lek przeciwgruźliczy.